Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Paramount Skydance is conducting a search for an executive to run the business side of news operations who would work alongside CBS News editor-in-chief Bari Weiss, sources told Axios. The role would extend to both CBS News and CNN if Paramount's proposed acquisition of Warner Bros Discovery is approved. The search follows staff exits at CBS progra…
Broadcom (AVGO) sold off after a post-earnings pullback despite record revenue and rapid AI-related ASIC growth. The company’s scale in custom AI silicon and infrastructure software, strong free cash flow, and defensive balance sheet make the recent dip a tactical buying opportunity. This trade idea lays out entry, stop, target and the risks that c…
Morgan Stanley analysts highlighted a subgroup of industrial companies they see as able to deliver organic growth above near-term forecasts, potentially prompting upward earnings revisions and higher relative valuations. The firm also named a set of companies that carry downside risk amid end-market pressures, and cautioned about possible second-ha…
A government official, speaking on condition of anonymity, said India has introduced bond-related steps aimed at achieving inclusion in the Bloomberg Aggregate Bond Index. Measures include ramped-up asset sales, a confirmed stake divestment in IDBI Bank, a request for increased fertilizer funding, a planned review of spending priorities in October-…
Photronics plunged after a disappointing Q2 print and ensuing headlines, but at roughly $30 the photomask specialist trades at low-teens earnings multiples, EV/EBITDA ~4.3 and only ~1.4x book. Strong cash flow generation, negligible leverage and secular demand drivers for photomasks create a favorable risk/reward for a long entry. This is a tactica…
BrainsWay Ltd. presented new 12-month durability data demonstrating that their FDA-cleared SWIFT™ accelerated Deep Transcranial Magnetic Stimulation (Deep TMS) protocol provides sustained remission in over 80% of Major Depressive Disorder patients, significantly improving functionality and quality of life with fewer clinic visits compared to standa…
Creative Realities, Inc. announced its inclusion in the Russell 3000 Index effective June 29, 2026, reflecting its growing market capitalization and integration of Cineplex Digital Media. This inclusion is expected to broaden its institutional investor base and affirm its growth strategy in digital signage and AdTech sectors.
CVRx, Inc., a NASDAQ-listed medical device company specializing in neuromodulation solutions for cardiovascular diseases, announced that CFO Jared Oasheim will step down to pursue other opportunities but will stay until a successor is appointed and remain an advisor through February 2027. Oasheim has been with the company since 2015 and helped lead…
FTI Consulting has appointed Sean O'Reilly, a seasoned healthcare executive with over 25 years of experience in compliance and regulatory risk management, as Senior Managing Director in its Healthcare Risk Management & Advisory practice. O'Reilly will leverage advanced analytics and AI to enhance clients' enterprise compliance programs, focusing on…
FitLife Brands, Inc. announced a new marketing partnership with renowned competitive eater Joey Chestnut to promote its Dr. Tobias Colon 14 Day Cleanse supplement. The 'Cleanse Like a Winner' campaign aims to connect wellness and digestive health with a champion mindset and leverages social media platforms to inspire consumers towards consistent he…
TG Therapeutics announced positive topline Phase 1 results for subcutaneous BRIUMVI (ublituximab-xiiy) in patients with myasthenia gravis (MG), showing significant clinical improvement and good tolerability. The company also initiated a potentially registration-directed Phase 2 trial to evaluate BRIUMVI as maintenance therapy following induction wi…
Corvus Pharmaceuticals announced a $5 million investment as part of a $13.5 million financing round for its collaboration partner Angel Pharmaceuticals. The funding will support ongoing and upcoming Phase 1b/2 clinical trials of soquelitinib for atopic dermatitis and asthma in China. Corvus retains a significant ownership stake in Angel Pharma and …
QTREX Quantum Ltd. announced receiving approximately $1 million from the Israel Innovation Authority to develop a specialized dielectric material optimized for high-density, low-loss RF signal routing in superconducting quantum computers. This development aims to overcome the key scaling challenges in quantum hardware connectivity by integrating ma…
SailPoint Inc. shares tumbled more than 15% in pre-market trading after the company reported fiscal first-quarter 2027 results that included a larger-than-expected per-share loss despite revenue growth. Management's guidance for the second quarter came in slightly below analyst consensus on earnings and roughly aligned on revenue for the year, whil…
JPMorgan’s weekly client survey, published Monday, found a modest rise in the net percentage of investors holding long positions in Treasury notes to 20% from 18% a week earlier. While a greater share of the full client base expects prices to rise, active clients are more divided and their net long exposure has fallen materially from the prior week…
The European Commission has unveiled a proposed 21st package of sanctions against Russia that targets the energy sector, financial institutions, maritime operations, certain metals and alloys, cryptocurrency services, and fish imports. Commission President Ursula von der Leyen announced the measures at a Brussels press conference, saying the packag…
Jumia Technologies AG stock climbed in pre-market trading as investors continued to react to the company's upbeat Q1 2026 results and recent governance moves. Aletheia Capital upgraded the shares to Buy and reiterated a $7.50 price target, while analysts and management staked out a path toward adjusted EBITDA breakeven by Q4 2026. No new company pr…
Kepler Cheuvreux has downgraded Uniqa Insurance Group from "buy" to "hold" while nudging its target price up to €17 from €16.50. The broker raised adjusted EPS forecasts for 2026-2028 and lifted valuation assumptions, saying the share rally has reduced upside and that there is "no immediate positive surprise potential" to materially boost earnings …
SCHMID Group N.V. has signed a preliminary agreement with local Chinese authorities to establish a new manufacturing campus in Zhongshan, Guangdong Province. The new facility will consolidate existing operations, nearly doubling manufacturing capacity to support increased demand for advanced electronics manufacturing equipment in China. The €11 mil…
CoreWeave Inc. is conducting outreach to European high-yield investors as it evaluates potential financing packages that could include both U.S. dollar and euro-denominated bonds. The company has engaged JP Morgan Chase & Co to organize investor calls and has amassed more than $20 billion of capital so far in 2026 through a combination of loan …
Indivior (INDV) is showing durable revenue growth from SUBLOCADE, raised 2026 guidance, and just refinanced debt with an accretive convertible notes package. The combination of improving fundamentals, reasonable valuation (P/E ~17.6; EV/EBITDA ~13.9) and technicals in a constructive range makes a mid-term long set-up attractive. Trade plan included…
Britain's Competition and Markets Authority has moved the proposed $110 billion acquisition of Warner Bros Discovery by Paramount Skydance into a formal phase 1 review. The CMA will examine whether the transaction could reduce competition in the UK, with a decision due by August 7 on whether to clear the deal or open a deeper investigation. The tak…
A wide plurality of economists now anticipate the Federal Reserve will keep its policy rate in the current 3.50%-3.75% range for the remainder of 2026 as inflation pushed higher by war-related energy shocks shows little sign of a rapid decline. A robust May jobs report and market pricing that implies at least one hike by the end of 2026 have dimini…
Alterity Therapeutics announced successful alignment with the U.S. FDA during the End-of-Phase 2 meeting, agreeing on key aspects of the planned Phase 3 clinical trial for ATH434 in treating Multiple System Atrophy (MSA). The FDA approved the study population, dosing regimen, treatment duration, primary and key secondary endpoints, and statistical …
Colliers (CIGI) still trades closer to brokerage multiples (PE ~59.7) despite building recurring, higher-margin businesses in engineering and investment management. Recent acquisitions and leadership moves strengthen the argument that current weakness is an entry point for a long-term trade. This idea lays out an exact entry, stop and target, with …
